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Abstract
Introduction
TheWorld Health Organization has solicited rapid and minimally invasive techniques to
facilitate scale-up of voluntary medical male circumcision (VMMC).
Study design
Non-blinded randomized controlled field trial with 2:1 allocation ratio.
Participants
75 adult male volunteers.
Setting
Outpatient primary care clinic.
Intervention
Open surgical circumcision under local anesthetic with suturing vs. Unicirc disposable
instrument under topical anesthetic and wound sealing with cyanoacrylate tissue adhesive.
Primary Outcome
Intraoperative duration.
Secondary Outcomes
Intraoperative and postoperative pain; adverse events; time to healing; patient satisfaction;
cosmetic result.
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Results
The intraoperative time was less with the Unicirc technique (median 12 vs. 25 min, p <
0.001). Wound healing and cosmetic results were superior in the Unicirc group. Adverse
events were similar in both groups.
Conclusions
VMMC with Unicirc under topical anesthetic and wound sealing with cyanoacrylate tissue
adhesive is rapid, heals by primary intention with superior cosmetic results, and is poten-
tially safer and more cost-effective than open surgical VMMC.
Trial Registration
Clinicaltrials.gov NCT02443792
Introduction
Voluntary medical male circumcision (VMMC) reduces female-to-male HIV transmission and
is a key element in the UNAIDS plan to end the global AIDS epidemic by 2030.[1] Cultural and
organizational challenges remain, and theWorld Health Organization (WHO) has solicited
improvements in VMMC techniques as an essential ingredient to enhance VMMC scale-up.[2]
The challenge is to develop circumcision methods suited to resource-limited settings and
which can be more easily adopted by mass circumcision campaigns without compromising
patient safety. The WHO recently approved two plastic ring devices, one of which is increas-
ingly used in HIV prevention programs.[3] While these devices require no sutures and have
few significant adverse events, the major drawback is they remain on the penis for one week,
resulting in necrosis at the base of the foreskin; consequently, healing is prolonged and occurs
by secondary intention.
The Unicirc surgical instrument uses an approach fundamentally different from plastic ring
devices and functions identically to the Gomco clamp used in early infant circumcision. It is a
single-use-only metal and plastic disposable surgical instrument, now in its second version.[4,
5] The Unicirc creates circumferential compression of the base of the foreskin, which fuses the
mucosal and skin surfaces and eliminates bleeding after the foreskin is excised. The fused skin
edges are sealed with cyanoacrylate adhesive to promote healing by primary intention. The
procedure does not require injectable anesthetic or sutures.
The objective of this randomized field trial was to compare the minimally invasive Unicirc tech-
nique to conventional open surgical circumcision for important clinical outcomes and adverse events.
Methods
This study was designed and conducted according to the guidelines found in WHO’s Frame-
work for Clinical Evaluation of Devices for Adult Male Circumcision[2] (Framework).
Trial design
This was a single-center non-blinded, parallel randomized controlled trial with 2:1 (Unicirc:
Surgical) allocation ratio in balanced blocks of 15.
The South African Medical Association’s Ethics Committee (SAMAREC) approved the
study and the informed consent. We obtained written informed consent from each participant.
Randomized Field Trial of Unicirc, a Single-Use Surgical Instrument
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All participants were adults. The procedures took place on four dates between July 15 and
August 7, 2015. The ClinicalTrials.gov identifier is NCT02443792.
Participants
Healthy uncircumcised men at least 16 years of age (the age of consent in S. Africa) were eligi-
ble for the study. Participants were recruited via posters and word of mouth. Men were
recruited from 3 clinics associated with Andrew Saffy Memorial hospital, serving the Lonmin
group of platinum mines, situated in Rustenberg, North West, South Africa.
We excluded volunteers with current illness, bleeding disorder, reaction to local anesthetic,
infection, or any penile abnormality potentially complicating circumcision.
All subjects had an HIV test performed as per hospital policy, and were referred appropri-
ately. No recruited volunteer was excluded because of HIV status and investigators were
unaware of HIV status.
We asked participants to abstain from sexual intercourse for at least 4 weeks after the cir-
cumcision and until the wound was completely healed. Condoms were made freely available.
Intervention
Two generalist doctors, experienced in surgical circumcision, performed all circumcisions
assisted by registered nurses in individual consultation rooms in a primary health care clinic.
Open surgical technique. After injecting a mixture of lidocaine 2% and bupivacaine as a
subcutaneous ring block at the base of the penis, circumcisions were performed with the for-
ceps-guided technique (RL) and the dorsal slit technique (LIM), as described in the WHO’s
Manual for Male Circumcision under Local Anesthesia.[6] After suturing with absorbable
sutures, the wound was covered with an absorbent gauze dressing.
Unicirc with cyanoacrylate skin adhesive. Training on the Unicirc method consisted of
demonstrations on a medical model, assisting several cases and then performing at least five
cases successfully under supervision before being certified as competent.
The surgical field was cleansed with povidone iodine and 5 gm of topical Lidocaine and pri-
locaine (EMLA™) was applied to the glans and foreskin 30 minutes prior to procedure. Sizing
was determined using a disposable sizing plate similar to that used for plastic ring devices.
Prior to use, the instruments were gas sterilized in sealed packages. The Unicirc instrument
was applied to the glans; the foreskin was then pulled over the transparent bell with the sur-
geon’s fingers and adjusted to ensure adequate removal of foreskin. No surgical instruments
were used to position the instrument. The Unicirc was then screwed tightly and left in place for
5 minutes before the foreskin was excised with a surgical scalpel. The Unicirc was removed and
the fused skin-mucosal edges were sealed with cyanoacrylate skin adhesive (Derma-Flex QS™).
Operative time was counted from the time the procedure was begun until the dressing was
applied (i.e. including the 5 minute waiting time). There were four different Unicirc diameters
used in the study: 2.6 cm, 2.9 cm, 3.2 cm, and 3.5 cm.
We covered the wound with Hypafix™ adhesive dressing and absorbent gauze. We
instructed participants to keep the wound dry, to leave the gauze in place until it became soiled,
and to remove the Hypafix™ after 3 weeks if it was still in place.
We observed participants for 30 minutes after the procedure, and gave them written postop-
erative instructions with cellular telephone contact information of the doctor.
Outcomes
Primary Outcome Measure. Intraoperative duration.
Randomized Field Trial of Unicirc, a Single-Use Surgical Instrument
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Secondary Outcome Measures. Intraoperative and postoperative pain; adverse events
(intraoperative and postoperative); wound disruption, healing at 4 weeks; patient satisfaction;
and, cosmetic result.
Adverse events. The Framework served as the guideline for evaluating adverse events
(AEs). Mild AEs required little or no intervention (e.g. slight bleeding), moderate AEs required
active treatment (e.g. antibiotics or suturing), and severe AEs required transfusion or hospitali-
zation, or resulted in permanent damage. Key AEs evaluated were anesthetic complications,
bleeding, hematoma, infection, problems with urination, subsequent procedures conducted to
correct complications or poor cosmetic results, and occupational exposure.
Sample Size
We based the sample size on the Framework which states: “Studies involving about 100 men
(range 50 to 300) are suggested as a compromise between assessing safety, documenting the
presumed advantages of the new method, and ensuring rapid progress through the different
stages of clinical assessment. For devices which are aids to surgery and do not stay on the
penis. . ..study sizes at the lower end 25–100 range may be sufficient.”
The sample size of 75 gave>90% power to detect a mean difference of 10 minutes in dura-
tion of surgery.
Randomization and implementation
An investigator who was not involved in the surgeries allocated participants in a 2:1 ratio using
a random number table; block randomization (in blocks of 15) was used to ensure exact 2:1
allocation. Each assignment was written on a slip of paper, folded, and placed in a sealed,
opaque envelope. Each envelope was opened only at the time of placement of the anesthetic.
Follow-up
Follow-up was at seven days and four weeks. If the wound was not completely healed by four
weeks, we conducted a six-week follow-up visit.
Outcome assessment
Outcome definitions are shown in Table 1. Intraoperative duration included the 5 minutes
waiting time after applying the Unicirc. The surgeons themselves assessed wound healing
outcomes.
We used a 10-point visual analog scale for the intraoperative and postoperative pain survey,
which was administered just prior to leaving the clinic. Satisfaction was assessed at the final
visit using a 5-point Likert scale.
Data analysis
Analysis was by intention-to-treat. We collected data from participants on socio-demographics
and reason for circumcision. HIV status was not recorded as part of the study protocol. We
analyzed data with Epi Info, version 7 (Atlanta, USA). For continuous variables, we used the
nonparametric Mann-Whitney/Wilcoxon two-sample test for comparison of outcomes. For
categorical variables, we used the chi-square or Fisher’s exact test.
Randomized Field Trial of Unicirc, a Single-Use Surgical Instrument
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Results
Participant flow
We recruited participants during May and June, 2015. Followup was completed in September,
2015. Although subjects at least 16 years of age were eligible, all participants were employees of
the mining company and were at least 18 years of age. The flow of participants in the study is
shown in Fig 1. A total of 84 men were interviewed and 75 (89%) participated in the study. All
participants received the intervention to which they were randomly assigned. One doctor
(LIM) performed 42 circumcisions and the other (RL) performed 33 circumcisions, each
approximately proportionately distributed between the Unicirc and surgical techniques.
Baseline data
The baseline characteristics of the participants are shown in Table 2. Most men gave improved
hygiene as their motivation for circumcision; one-third were motivated by a potential reduc-
tion in HIV infection. There were no significant differences in baseline characteristics between
the two groups.
Outcomes analyzed
Table 3 shows operative outcomes. Intraoperative and postoperative pain was minimal in both
groups. Intraoperative duration and blood loss were less with the Unicirc method, median
duration 12 vs. 25 min (p< 0.001) and median blood loss 1.5 vs 40 ml (p< 0.001).
Table 4 shows adverse events. Two intraoperative complications occurred using the Unicirc
instrument. In one case, the doctor neglected to tighten the Unicirc; in the second case, the
Unicirc was mis-packaged by staff and the size of the bell did not match the size of the yoke,
resulting in inadequate compression. Each of the two procedures was completed surgically;
both were analyzed in the Unicirc group to which they were assigned. There was one bleeding
episode, which occurred two hours following a Unicirc procedure and was sutured. None of
the 3 hematomas in the surgical group required intervention. There were no significant differ-
ences between the two groups in bleeding, hematoma, infection, or any other complication.
Table 1. Outcome definitions.
Outcome Deﬁnition
Pain assessment using Visual
Analog Scale (0–10)
Self-reported intraoperative and immediate postoperative pain
Blood loss Estimated by surgeon (ml)
Intraoperative duration From the moment the procedure was started until dressing placed
Adverse Event Mild adverse events: no active intervention other than wound
pressure for bleeding. Moderate events: medical intervention
(sutures, antibiotics). Severe events: transfusion; hospitalization;
or resulted in permanent disﬁgurement
Wound infection Wound swelling, redness, pain, purulent discharge
Wound disruption Length of wound disruption (< 2cm vs. > 2cm)
Wound fully healed Wound completely closed. No superﬁcial ulcerations or
granulation tissue present
Cosmetic appearance Regular: scar line straight with no irregularity
Irregular: Some irregularity to scar line
Scalloped: wavy appearance to scar line
Participant satisfaction (5 point
Likert scale)
Are you satisﬁed with your circumcision result?
doi:10.1371/journal.pone.0157065.t001
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Healing, participant satisfaction, and cosmetic results are shown in Table 5. Eighteen subjects
[14 Unicirc (28%) and 4 surgical (16%)] experienced minor (< 2 cm length) wound disruptions
at the one-week followup visit. The Unicirc wound disruptions were accompanied by loosening
of the Hypafix™, suggesting that they had been chronically wet. No wound disruptions required
intervention, all healed uneventfully, and we did not consider them adverse events.
One of the seven subjects in the Unicirc group who did not return for the 28-day followup
visit was successfully contacted by phone to administer the satisfaction survey. Unicirc subjects
Fig 1. Participant Flow Diagram.
doi:10.1371/journal.pone.0157065.g001
Randomized Field Trial of Unicirc, a Single-Use Surgical Instrument
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were more likely to be fully healed at 4 weeks (90.7% vs 69.6%; p = 0.04). Satisfaction was high and
equal in both groups. The cosmetic result was superior in the Unicirc group; a regular scar line was
found in 40 (93.0%) of the Unicirc subjects vs. 2 (9.5%) in the surgical group (p< 0.001).
Discussion
Scale-up of VMMC to prevent HIV infection in Africa has now exceeded 9 million men, which
is well belowWHO’s goal of 20.8 million men in 14 high priority African countries by 2016.[7]
In order to more effectively scale-up services, we require fundamental improvements in cir-
cumcision techniques and programs.
Table 2. Baseline characteristics.
Unicirc (N = 50) Open surgical (N = 25)
Age (yrs), n (%)
18–25 3 (6) 2 (8)
26–35 19 (38) 12 (48)
36+ 28 (56) 11 (44)
Median age (yrs) 37.5 34
Marital status, n (%)
Married 29 (58) 9 (36)
Single in a relationship 19 (38) 16 (64)
No partner 2 (4) 0
Religion, n (%)
Christian 29 (58) 20 (80)
Muslim 0 0
African Independent 2 (4) 0
No religion 10 (20) 2 (8)
Other 9 (18) 3 (12)
Highest educational level, n (%)
No primary 2 (4) 2 (8)
Primary 10 (20) 1 (4)
Secondary 38 (76) 21 (84)
Post-secondary 0 1 (4)
Reason for circumcision, n (%)
Hygiene 25 (50) 13 (52)
Reduce HIV infection 14 (28) 10 (40)
Appearance 3 (6) 0
Social/religious 1 (2) 0
Sexual pleasure 3 (6) 2 (8)
Other 4 (8) 0
doi:10.1371/journal.pone.0157065.t002
Table 3. Operative outcomes.
Unicirc Open surgical
Operative duration (min), median (IQR)* 12 (11,17) 25 (21,35)
Estimated blood loss (ml), median (IQR)* 1.5 (1,2) 40 (40,50)
Intraoperative Pain (10 point scale), median (IQR) 1.0 (0.5,2) 1.0 (0,2)
Postoperative pain (10 point scale), median (IQR) 1.0 (0.5,2) 1.0 (0,5)
IQR = Interquartile range
*P < 0.001
doi:10.1371/journal.pone.0157065.t003
Randomized Field Trial of Unicirc, a Single-Use Surgical Instrument
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This study showed that, compared to surgical VMMC, the Unicirc method had a shorter
procedure time, more rapid healing, better cosmetic appearance, and similar adverse events.
The generalist doctors in this study were highly experienced in open surgical circumcision
but had not previously used the Unicirc instrument outside of training. Operative duration was
longer than in previous studies,[4, 5] but Unicirc required approximately half the operative time
compared to the surgical technique. We believe that the relatively long operative times were the
result of the surgical style of the two participating doctors. We expect even greater time-savings
as the generalist doctors gain more experience with the Unicirc method. Because the Unicirc
operative duration includes 5 minutes of waiting for the tissues to fuse, multiple procedures can
be performed simultaneously using theWHO’s MOVEmodel of task-sharing.[8]
Unicirc requires no surgical instruments other than a scalpel, no injectable anesthetic, and
no sutures. The retail cost of a sterile pack for a Unicirc circumcision is US$5 versus US$20 for
the surgical pack, Derma-Flex QS US$15.50, and EMLA cream US$4.30 in South Africa. The
cost of the Unicirc has not been determined but will likely be similar to plastic ring devices.
Men can return to work the next day and do not need to take a day off work for a one-week
device removal visit. Because there is never an open wound, Unicirc can be performed as a
clean, rather than a sterile, procedure. These factors and the substantial time-savings with Uni-
circ are likely to substantially reduce overall cost and assist in mass VMMC scale-up. However,
a formal economic evaluation is required to quantify the overall cost of the Unicirc method
compared to other techniques.
Table 4. Adverse events.
Unicirc Open surgical
Intraoperative suturing, n (%) 2 (4) All by protocol
Serious postoperative complication, n 0 0
Postoperative bleeding, n (%)
Mild (dressing only) 0 1 (4)
Moderate (sutured) 1 (2) 0
Hematoma, n (%) 0 3 (12)
Postoperative infection (requiring antibiotic), n (%) 0 0
P > 0.05 for all comparisons
doi:10.1371/journal.pone.0157065.t004
Table 5. Postoperative outcomes.
Unicirc Open surgical P value
Wound disruption at 1 wk, n (%)
< 2 cm length 14 (28) 4 (16) NS
> 2 cm length 0 0
Wound fully healed at 4 weeks, n (%) 39 (90.7) 16 (69.6) 0.04
Satisfaction, n (%)
Very satisﬁed 43 (97.7) 22 (95.7) NS
Satisﬁed 1 (2.3) 1 (4.4)
Not satisﬁed 0 0
Cosmetic results, n (%)
Regular 40 (93.0) 2 (9.5) P < 0.001
Irregular 3 (7.0) 6 (28.6)
Scalloped 0 13 (61.9)
doi:10.1371/journal.pone.0157065.t005
Randomized Field Trial of Unicirc, a Single-Use Surgical Instrument
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Adverse events were low with no significant differences between groups. There were 2
intraoperative complications with Unicirc, one related to surgical inattention and one related
to faulty packaging by staff. The Unicirc kit is now pre-packaged at the factory to prevent mis-
matching of parts.
One Unicirc participant experienced postoperative bleeding which required suture. In the
first study with this instrument, there were no postoperative bleeds in 50 subjects;[5] in the sec-
ond study, postoperative bleeding occurred in 5 (4.5%) subjects.[4] As in the prior studies,
there were no hematomas with Unicirc. Because of the small risk of postoperative bleeding, we
recommend that sites capable of suturing perform Unicirc circumcisions.
This study showed superior healing and cosmetic results using the Unicirc method. Absorb-
able sutures frequently cause small ulcerations at the entry and exit points, which probably
accounted for the differences in healing. There were 28% minor wound disruptions following
Unicirc (vs. 16% following surgical), but they were not clinically important and did not delay
overall healing.
After numerous paediatric[9–14] and adult[4, 5, 15–20] studies, there remains no doubt
that cyanoacrylate tissue adhesive is superior to sutures in VMMC. We used high viscosity,
quick-setting 2-octyl cyanoacrylate, which applied easily and cured quickly. The one clear
caveat is that the wound must be kept dry postoperatively; nothing adheres to macerated skin.
The use of topical anesthetic, coupled with this sutureless technique, will reduce the risk of
needlestick injuries and therefore the transmission of blood borne infections.
This field study was unblinded and was performed at a single center by two doctors. Wound
healing was assessed by the doctors themselves and there was no independent assessment. Fol-
lowup at four weeks was not complete, but we feel that all adverse events were accounted for,
since followup at 7 days was complete and almost all VMMC complications occur in the first
week. The study was underpowered to evaluate adverse events, but neither this nor prior Uni-
circ studies have shown elevated adverse event rates compared to other methods.
Two plastic ring devices have been approved by WHO and are now being used in HIV pre-
vention programs. However, healing is delayed by secondary intention, so these devices do not
meet the criterion laid out in WHO’s Framework that new devices have “more rapid healing
than current methods and/or might entail less risk of HIV transmission in the immediate post-
operative period.”[2] Furthermore, the fact that the placement of plastic ring devices is faster
than surgical circumcision is misleading, because the necessity for a second visit for device
removal nullifies any time advantage. There is direct evidence of HIV shedding from unhealed
circumcision wounds in HIV-infected men at 3 weeks, suggesting caution in using plastic ring
devices because of delayed healing by secondary intention.[21] It is also likely that increased
HIV acquisition may occur among men who have sex with HIV-infected partners prior to
complete healing of circumcision wounds. Tetanus is probably more likely to occur with plastic
ring devices than other methods due to the presence of necrotic material.[22]
Conclusions
VMMC with Unicirc under topical anesthetic and wound sealing with cyanoacrylate tissue
adhesive is rapid, heals by primary intention, has superior cosmetic results, and is potentially
safer than open surgical VMMC.
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